| Issue Date |
Title |
Author(s) |
| 2020 |
Altered resting-state dynamic functional brain networks in major depressive disorder: Findings from the REST-meta-MDD consortium |
Long, Yicheng;Cao, Hengyi;Yan, Chaogan;Chen, Xiao;Li, Le;Castellanos, Francisco Xavier;Bai, Tongjian;Bo, Qijing;Chen, Guanmao;Chen, Ningxuan;Chen, Wei;Cheng, Chang;Cheng, Yuqi;Cui, Xilong;Duan, Jia;Fang, Yiru;Gong, Qiyong;Guo, Wenbin;Hou, Zhenghua;Hu, Lan;Kuang, Li;Li, Feng;Li, Kaiming;Li, Tao;Liu, Yansong;Luo, Qinghua;Meng, Huaqing;Peng, Daihui;Qiu, Haitang;Qiu, Jiang;Shen, Yuedi;Shi, Yushu;Si, Tianmei;Wang, Chuanyue;Wang, Fei;Wang, Kai;Wang, Li;Wang, Xiang;Wang, Ying;Wu, Xiaoping;Wu, Xinran;Xie, Chunming;Xie, Guangrong;Xie, Haiyan;Xie, Peng;Xu, Xiufeng;Yang, Hong;Yang, Jian;Yao, Jiashu;Yao, Shuqiao;Yin, Yingying;Yuan, Yonggui;Zhang, Aixia;Zhang, Hong;Zhang, Kerang;Zhang, Lei;Zhang, Zhijun;Zhou, Rubai;Zhou, Yiting;Zhu, Junjuan;Zou, Chaojie;Zang, Yufeng;Zhao, Jingping;Chan, Calais Kin-yuen;Pu, Weidan;Liu, Zhening |
| 1-Jan-2022 |
The association of depressive symptoms with disability among adults in China |
Peng, Rui;Wang, Yongshi;Huang, Yueqin;Liu, Zhaorui;Xu, Xiangdong;Ma, Yanjuan;Wang, Limin;Zhang, Mei;Yan, Yongping;Wang, Bo;Xiao, Shuiyuan;Zhou, Liang;Li, Lingjiang;Zhang, Yan;Ma, Chao;Zhang, Tingting;Yan, Jie;Ding, Hua;Yu, Yaqin;Kou, Changgui;Xu, Xiufeng;Lu, Jin;Wang, Zhizhong;He, Shulan;Xu, Yifeng;He, Yanling;Li, Tao;Guo, Wanjun;Xu, Guangming;Yin, Huifang;Du, Xiangdong;Wu, Yue;Li, Guohua;Jia, Fujun;Shi, Jianfei;Chen, Zheli;Zhang, Ning;Li, Shengju |
| 2016 |
The China Mental Health Survey (CMHS): I. background, aims and measures |
Huang, Yueqin;Liu, Zhaorui;Wang, Hong;Guan, Xing;Chen, Hongguang;Ma, Chao;Li, Qiang;Yan, Jie;Yu, Yaqin;Kou, Changgui;Xu, Xiufeng;Lu, Jin;Wang, Zhizhong;Liu, Lan;Xu, Yifeng;He, Yanling;Li, Tao;Guo, Wanjun;Tian, Hongjun;Xu, Guangming;Xu, Xiangdong;Lv, Shuyun;Wang, Linhong;Wang, Limin;Yan, Yongping;Wang, Bo;Xiao, Shuiyuan;Zhou, Liang;Li, Lingjiang;Tan, Liwen |
| 2016 |
The China Mental Health Survey: II. Design and field procedures |
Liu, Zhaorui;Huang, Yueqin;Lv, Ping;Zhang, Tingting;Wang, Hong;Li, Qiang;Yan, Jie;Yu, Yaqin;Kou, Changgui;Xu, Xiufeng;Lu, Jin;Wang, Zhizhong;Qiu, Hongyan;Xu, Yifeng;He, Yanling;Li, Tao;Guo, Wanjun;Tian, Hongjun;Xu, Guangming;Xu, Xiangdong;Ma, Yanjuan;Wang, Linhong;Wang, Limin;Yan, Yongping;Wang, Bo;Xiao, Shuiyuan;Zhou, Liang;Li, Lingjiang;Tan, Liwen;Chen, Hongguang;Ma, Chao |
| 4-Jul-2022 |
The Chinese Brief Cognitive Test: Normative Data Stratified by Gender, Age and Education |
Ye, Shuling;Xie, Mengjuan;Yu, Xin;Wu, Renrong;Liu, Dengtang;Hu, Shaohua;Xu, Yong;Liu, Huanzhong;Wang, Xijin;Zhu, Gang;Wang, Huaning;Zou, Shaohong;Li, Tao;Guo, Wanjun;Xu, Xiufeng;Cheng, Yuqi;Li, Yi;Yang, Juan;Peng, Min;Li, Nan;Shi, Chuan |
| Oct-2020 |
Clinical characteristics of familial schizophrenia |
Liu, Na;Zhou, Hui;Xiong, Xiangyu;Li, Qingwei;Jiang, Xuefeng;Zhao, Jingping;Yang, Xiaoxin;Zhang, Mingyuan;Wang, Xiangqun;Wang, Gang;Yang, Fude;Hu, Jian;Zhang, Xinjun;Du, Lingyang;Li, Huichun;Feng, Bing;Hu, Zhenyu;Chen, Zuoming;Wang, Chunxia;Wang, Xilin;Zhang, Jinbei;Liu, Tiebang;Jia, Fujun;Sun, Xueli;Xu, Xiufeng;Meng, Huaqing;Wang, Gaohua;Zhang, Ning;Mei, Qiyi;Tan, Qingrong;Peng, Chunqing;Li, Jing;Lu, Zheng |
| Mar-2022 |
Connectome gradient dysfunction in major depression and its association with gene expression profiles and treatment outcomes |
Xia, Mingrui;Liu, Jin;Mechelli, Andrea;Sun, Xiaoyi;Ma, Qing;Wang, Xiaoqin;Wei, Dongtao;Chen, Yuan;Liu, Bangshan;Huang, Chu-Chung;Zheng, Yanting;Wu, Yankun;Chen, Taolin;Cheng, Yuqi;Xu, Xiufeng;Gong, Qiyong;Si, Tianmei;Qiu, Shijun;Lin, Ching-Po;Cheng, Jingliang;Tang, Yanqing;Wang, Fei;Qiu, Jiang;Xie, Peng;Li, Lingjiang;He, Yong |
| 2019 |
Design, synthesis, and biological evaluation of 4-aminopyrimidine or 4,6-diaminopyrimidine derivatives as beta amyloid cleaving enzyme-1 inhibitors |
Xu, Xiufeng;Lue, Peng;Wang, Junjie;Xu, Fengrong;Liang, Lei;Wang, Chao;Niu, Yan;Xu, Ping |
| 2016 |
Efficacy and safety of quetiapine extended release monotherapy in bipolar depression: a multi-center, randomized, double-blind, placebo-controlled trial |
Li, Huafang;Gu, Niufan;Zhang, Hongyan;Wang, Gang;Tan, Qingrong;Yang, Fude;Ning, Yuping;Zhang, Honggeng;Lu, Zheng;Xu, Xiufeng;Shi, Jianguo;Gao, Chengge;Li, Lingjiang;Zhang, Kerang;Tian, Hongjun;Wang, Xiaoping;Li, Keqing;Li, Huichun;Xu, Yi;Xie, Shiping;Yu, Xin |
| 17-Mar-2022 |
Efficacy, Safety, and Tolerability of Ansofaxine (LY03005) Extended-Release Tablet for Major Depressive Disorder: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding, Phase 2 Clinical Trial |
Mi, Weifeng;Yang, Fude;Li, Huafang;Xu, Xiufeng;Li, Lehua;Tan, Qingrong;Wang, Guoqiang;Zhang, Kerang;Tian, Feng;Luo, Jiong;Xia, Jielai;Yuan, Kai;Lu, Lin;Deng, Jiahui;Tian, Jingwei;Zhang, Hongyan |
| 2010 |
INTRAMUSCULAR ZIPRASIDONE HAS IMPROVED TOLERABILITY OVER HALOPERIDOL AND COMPARABLE EFFICACY FOR CONTROL OF AGITATION IN SCHIZOPHRENIA IN CHINESE PATIENTS |
Shu, Liang;Zhang, Hongyan;Wang, Gang;Zhao, Jingping;Xie, Shiping;Xu, Xiufeng;Shi, Jianguo;Deng, Hehuang;Li, Keqing;Gao, Chengge;Wang, Xiaoping;Karayal, Onur;Vanderburg, Douglas;Pan, Sharon;Tang, Haiyun |
| 2013 |
Intramuscular Ziprasidone Versus Haloperidol for Managing Agitation in Chinese Patients With Schizophrenia |
Zhang, Hongyan;Wang, Gang;Zhao, Jingping;Xie, Shiping;Xu, Xiufeng;Shi, Jianguo;Deng, Hehuang;Li, Keqing;Gao, Chengge;Wang, Xiaoping;Vanderburg, Douglas;Pan, Sharon;Tang, Haiyun;Shu, Liang;Karayal, Onur N. |
| 2015 |
The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China |
Shi, Chuan;Kang, Lan;Yao, Shuqiao;Ma, Yibin;Li, Tao;Liang, Ying;Cheng, Zhang;Xu, Yifeng;Shi, Jianguo;Xu, Xiufeng;Zhang, Congpei;Franklin, Donald R.;Heaton, Robert K.;Jin, Hua;Yu, Xin |
| Mar-2020 |
A neuroimaging biomarker for striatal dysfunction in schizophrenia |
Li, Ang;Zalesky, Andrew;Yue, Weihua;Howes, Oliver;Yan, Hao;Liu, Yong;Fan, Lingzhong;Whitaker, Kirstie J.;Xu, Kaibin;Rao, Guangxiang;Li, Jin;Liu, Shu;Wang, Meng;Sun, Yuqing;Song, Ming;Li, Peng;Chen, Jun;Chen, Yunchun;Wang, Huaning;Liu, Wenming;Li, Zhigang;Yang, Yongfeng;Guo, Hua;Wan, Ping;Lv, Luxian;Lu, Lin;Yan, Jun;Song, Yuqing;Wang, Huiling;Zhang, Hongxing;Wu, Huawang;Ning, Yuping;Du, Yuhui;Cheng, Yuqi;Xu, Jian;Xu, Xiufeng;Zhang, Dai;Wang, Xiaoqun;Jiang, Tianzi;Liu, Bing |
| 2007 |
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil |
Lee, Phil;Shu, Liang;Xu, Xiufeng;Wang, Chuan Yue;Lee, Min Soo;Liu, Chia-Yih;Hong, Jin Pyo;Ruschel, Sandra;Raskin, Joel;Colman, Samuel A.;Harrison, Gavan A. |
| Nov-2021 |
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study |
Lu, Jin;Xu, Xiufeng;Huang, Yueqin;Li, Tao;Ma, Chao;Xu, Guangming;Yin, Huifang;Xu, Xiangdong;Ma, Yanjuan;Wang, Limin;Huang, Zhengjing;Yan, Yongping;Wang, Bo;Xiao, Shuiyuan;Zhou, Liang;Li, Lingjiang;Zhang, Yan;Chen, Hongguang;Zhang, TingTing;Yan, Jie;Ding, Hua;Yu, Yaqin;Kou, Changgui;Shen, Zonglin;Jiang, Linling;Wang, Zhizhong;Sun, Xian;Xu, Yifeng;He, Yanling;Guo, Wanjun;Jiang, Lijun;Li, Shengyan;Pan, Wen;Wu, Yue;Li, Guohua;Jia, Fujun;Shi, Jianfei;Shen, Zhongxia;Zhang, Ning |
| 2019 |
Prevalence of mental disorders in China: a cross-sectional epidemiological study |
Huang, Yueqin;Wang, Yu;Wang, Hong;Liu, Zhaorui;Yu, Xin;Yan, Jie;Yu, Yaqin;Kou, Changgui;Xu, Xiufeng;Lu, Jin;Wang, Zhizhong;He, Shulan;Xu, Yifeng;He, Yanling;Li, Tao;Guo, Wanjun;Tian, Hongjun;Xu, Guangming;Xu, Xiangdong;Ma, Yanjuan;Wang, Linhong;Wang, Limin;Yan, Yongping;Wang, Bo;Xiao, Shuiyuan;Zhou, Liang;Li, Lingjiang;Tan, Liwen;Zhang, Tingting;Ma, Chao;Li, Qiang;Ding, Hua;Geng, Hongchun;Jia, Fujun;Shi, Jianfei;Wang, Shiliang;Zhang, Ning;Du, Xinbai;Du, Xiangdong;Wu, Yue |
| Jan-2020 |
Randomized, double-blind, 6-week non-inferiority study of lurasidone and risperidone for the treatment of schizophrenia |
Feng, Yuan;Shi, Jianguo;Wang, Lili;Zhang, Xia;Tan, Yunlong;Zhao, Jingyuan;Ning, Yuping;Xie, Shiping;Liu, Xuejun;Liu, Qi;Li, Keqing;Wang, Xiaoliang;Li, Lehua;Xu, Xiufeng;Deng, Wei;Luo, Xiaoyan;Wang, Gang |
| 2020 |
Towards Automated Migration for Blockchain-based Decentralized Application |
Xu, Xiufeng |
| 2019 |
What is the optimal neuropsychological test battery for schizophrenia in China? |
Shi, Chuan;Kang, Lan;Yao, Shuqiao;Ma, Yibin;Li, Tao;Liang, Ying;Cheng, Zhang;Xu, Yifeng;Shi, Jianguo;Xu, Xiufeng;Zhang, Congpei;Franklin, Donald R.;Heaton, Robert K.;Jin, Hua;Yu, Xin |
